Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Prospective, Observational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in Progressive Chronic Kidney Disease Patients.

NCT07930169 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07930169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Prospective, Observational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in Progressive Chronic Kidney Disease Patients.
Lead sponsor
HK inno.N Corporation
Phase
Observational
Overall status
Recruiting
Start date
July 18, 2023
Completion date
December 31, 2027
Enrollment
3,125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Proportion of participants with an effective overall assessment at Week 24 Baseline to Week 24 (Week 24 ±3 weeks)

    Overall effectiveness will be assessed by the investigator based on serum creatinine (Scr) and estimated glomerular filtration rate (eGFR). Participants will be classified as effective, ineffective, or unevaluable; unevaluable participants will be excluded from the analysis.

Lead sponsor's other trials

HK inno.N Corporation, most recent start first.

Similar trials

Same condition (Renal Insufficiency, Chronic) and phase, most recent start first.